Occult breast cancer in an older woman: A case report
- Authors:
- Cong Liu
- Hua Xing
-
Affiliations: Department of Breast Surgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China - Published online on: December 24, 2024 https://doi.org/10.3892/etm.2024.12788
- Article Number: 38
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP and Petrek JA: Occult breast cancer presenting with axillary metastases: Updated Management. Arch Surg. 125:210–214. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Sohn G, Son BH, Lee SJ, Kang EY, Jung SH, Cho SH, Baek S, Lee YR, Kim HJ, Ko BS, et al: Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: A nationwide retrospective study. J Surg Oncol. 110:270–274. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Patel J, Nemoto T, Rosner D, Dao TL and Pickren JW: Axillary lymph node metastasis from an occult breast cancer. Cancer. 47:2923–2927. 1981.PubMed/NCBI View Article : Google Scholar | |
|
Huang Y, Wu H and Luo Z: A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy? Medicine (Baltimore). 96(e9490)2017.PubMed/NCBI View Article : Google Scholar | |
|
Yamaguchi H, Ishikawa M, Hatanaka K, Uekusa T, Ishimaru M and Nagawa H: Occult breast cancer presenting as axillary metastases. Breast. 15:259–262. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Abe S, Abe N, Noda M, Okano M, Tachibana K, Yoshida S, Kiko Y, Hashimoto Y, Hatakeyama Y, Rokkaku Y and Ohtake T: A Case of Occult Breast Cancer. Gan To Kagaku Ryoho. 44:1095–1097. 2017.PubMed/NCBI(In Japanese). | |
|
Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA and Buchholz TA: Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer. 116:4000–4006. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Frattaroli FM, Carrara A, Conte AM and Pappalardo G: Axillary metastasis as first symptom of occult breast cancer: A case report. Tumori. 88:532–534. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Zhang J, Chen M, Ren S, Liu H and Zhang H: Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report. Medicine (Baltimore). 96(e8529)2017.PubMed/NCBI View Article : Google Scholar | |
|
Woo SM, Son BH, Lee JW, Kim HJ, Yu JH, Ko BS, Sohn G, Lee YR, Kim H, Ahn SH and Baek SH: Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: A single center experience. J Breast Cancer. 16:410–416. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Coleman C: Early detection and screening for breast cancer. Semin Oncol Nurs. 33:141–155. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Anderson WF, Jatoi I and Devesa SS: Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat. 99:333–340. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Nguyen QD, Randall JW, Harmon TS, Robinson AS, Cotes C, Lee AE, Mahon BH and Sadruddin S: Detection of a mammographically occult breast cancer with a challenging clinical history. Cureus. 10(e3594)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lee J and Nishikawa RM: Identifying women with mammographically-occult breast cancer leveraging GAN-Simulated Mammograms. IEEE Trans Med Imaging. 41:225–236. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Tartter PI, Weiss S, Ahmed S, Kamath S, Hermann G and Drossman S: Mammographically occult breast cancers. Breast J. 5:22–25. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Prasad SN and Houserkova D: The role of various modalities in breast imaging. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 151:209–218. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Planche K and Vinnicombe S: Breast imaging in the new era. Cancer Imaging. 4:39–50. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Sánchez LR, Treviño LMT and Sánchez GE: Fusion of Digital Mammography with High-Resolution Breast PET: An Application to Breast Imaging. In: 2nd EAI International Conference on Smart Technology. Torres-Guerrero F, Neira-Tovar L and Bacca-Acosta J (eds). Springer International Publishing, Cham, pp111-125, 2023. | |
|
Fiorica JV: Breast cancer screening, mammography, and other modalities. Clin Obstet Gynecol. 59:688–709. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Rodriguez-Ruiz A, Lång K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, Helbich TH, Chevalier M, Tan T, Mertelmeier T, et al: Stand-Alone artificial intelligence for breast cancer detection in mammography: Comparison with 101 radiologists. J Natl Cancer Inst. 111:916–922. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Groheux D, Espié M, Giacchetti S and Hindié E: Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 266:388–405. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Radan L, Ben-Haim S, Bar-Shalom R, Guralnik L and Israel O: The role of FDG-PET/CT in suspected recurrence of breast cancer. Cancer. 107:2545–2551. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C and Fazio F: PET/CT and breast cancer. Eur J Nucl Med Mol Imaging. 31 (Suppl 1):S135–S142. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, et al: Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 20:691–722. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhao YF, Chen Z, Zhang Y, Zhou J, Chen JH, Lee KE, Combs FJ, Parajuli R, Mehta RS, Wang M and Su MY: Diagnosis of breast cancer using radiomics models built based on dynamic contrast enhanced MRI combined with mammography. Front Oncol. 11(774248)2021.PubMed/NCBI View Article : Google Scholar | |
|
Merson M, Andreola S, Galimberti V, Bufalino R, Marchini S and Veronesi U: Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 70:504–508. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Varadarajan R, Edge SB, Yu J, Watroba N and Janarthanan BR: Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 71:456–459. 2006.PubMed/NCBI View Article : Google Scholar | |
|
He M, Tang LC, Yu KD, Cao AY, Shen ZZ, Shao ZM and Di GH: Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer. Eur J Surg Oncol. 38:1022–1028. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Khandelwal AK and Garguilo GA: Therapeutic options for occult breast cancer: A survey of the American Society of Breast Surgeons and review of the literature. Am J Surg. 190:609–613. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Halsted WS: I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 46:1–19. 1907.PubMed/NCBI View Article : Google Scholar | |
|
Lloyd MS and Nash AG: ‘Occult’ breast cancer. Ann R Coll Surg Engl. 83:420–424. 2001.PubMed/NCBI | |
|
Ofri A and Moore K: Occult breast cancer: Where are we at? Breast. 54:211–215. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wong YP, Tan GC, Muhammad R and Rajadurai P: Occult primary breast carcinoma presented as an axillary mass: A diagnostic challenge. Malays J Pathol. 42:151–155. 2020.PubMed/NCBI | |
|
Xu R, Li J, Zhang Y, Jing H and Zhu Y: Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review. Medicine (Baltimore). 96(e9312)2017.PubMed/NCBI View Article : Google Scholar | |
|
Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, Hunt KK, Ross MI, Buchholz TA, Buzdar AU and Singletary SE: Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 8:425–431. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Fayanju OM, Jeffe DB and Margenthaler JA: Occult primary breast cancer at a comprehensive cancer center. J Surg Res. 185:684–689. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Terada M, Adachi Y, Sawaki M, Hattori M, Yoshimura A, Naomi G, Kotani H, Iwase M, Kataoka A, Onishi S, et al: Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes. Breast Cancer Res Treat. 172:1–7. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kadowaki M, Nagashima T, Sakata H, Sakakibara M, Sangai T, Nakamura R, Fujimoto H, Arai M, Onai Y, Nagai Y, et al: Ectopic breast tissue in axillary lymph node. Breast Cancer. 14:425–428. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Edlow DW and Carter D: Heterotopic epithelium in axillary lymph nodes: Report of a case and review of the literature. Am J Clin Pathol. 59:666–673. 1973.PubMed/NCBI View Article : Google Scholar | |
|
Turner DR and Millis RR: Breast tissue inclusions in axillary lymph nodes. Histopathology. 4:631–636. 1980.PubMed/NCBI View Article : Google Scholar | |
|
Maiorano E, Mazzarol GM, Pruneri G, Mastropasqua MG, Zurrida S, Orvieto E and Viale G: Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol. 27:513–518. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Locopo N, Fanelli M and Gasparini G: Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat. 52:159–173. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Blanchard DK, Shetty PB, Hilsenbeck SG and Elledge RM: Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 247:732–738. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Olson JA Jr, Morris EA, Van Zee KJ, Linehan DC and Borgen PI: Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 7:411–415. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Sanuki JI, Uchida Y, Uematsu T, Yamada Y and Kasami M: Axillary mass suspected to be occult breast carcinoma: A case study of skipped axillary lymph node metastasis from endometrial carcinoma in which core-needle biopsy was useful for diagnosis. Breast Cancer. 16:72–76. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Hulka CA, Smith BL, Sgroi DC, Tan L, Edmister WB, Semple JP, Campbell T, Kopans DB, Brady TJ and Weisskoff RM: Benign and malignant breast lesions: Differentiation with echo-planar MR imaging. Radiology. 197:33–38. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Bhatia SK, Saclarides TJ, Witt TR, Bonomi PD, Anderson KM and Economou SG: Hormone receptor studies in axillary metastases from occult breast cancers. Cancer. 59:1170–1172. 1987.PubMed/NCBI View Article : Google Scholar | |
|
Poulakaki F: Occult Breast Cancer. In: Breast Cancer Essentials. Rezai M, Kocdor MA and Canturk NZ (eds). Springer International Publishing, Cham, pp667-674, 2021. | |
|
Van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW and Hillen HF: Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer. 38:409–413. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Randén M, Rutqvist LE and Johansson H: Cancer patients without a known primary: Incidence and survival trends in Sweden 1960-2007. Acta Oncol. 48:915–920. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Hemminki K, Bevier M, Hemminki A and Sundquist J: Survival in cancer of unknown primary site: Population-based analysis by site and histology. Ann Oncol. 23:1854–1863. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Pentheroudakis G, Lazaridis G and Pavlidis N: Axillary nodal metastases from carcinoma of unknown primary (CUPAx): A systematic review of published evidence. Breast Cancer Res Treat. 119:1–11. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Brewster DH, Lang J, Bhatti LA, Thomson CS and Oien KA: Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Cancer Epidemiol. 38:227–234. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Binder C, Matthes KL, Korol D, Rohrmann S and Moch H: Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling. Cancer Med. 7:4814–4824. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Krämer A, Hübner G, Schneeweiss A, Folprecht G and Neben K: Carcinoma of unknown primary-an orphan disease? Breast Care (Basel). 3:164–170. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Barbieri E, Anghelone CAP, Gentile D, La Raja C, Bottini A and Tinterri C: Metastases from occult breast cancer: A case report of carcinoma of unknown primary Syndrome. Case Rep Oncol. 13:1158–1163. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Krämer A, Bochtler T, Pauli C, Baciarello G, Delorme S, Hemminki K, Mileshkin L, Moch H, Oien K, Olivier T, et al: Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 34:228–246. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Urban D, Rao A, Bressel M, Lawrence YR and Mileshkin L: Cancer of unknown primary: A population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 109:1318–1324. 2013.PubMed/NCBI View Article : Google Scholar | |
|
de Bresser J, de Vos B, van der Ent F and Hulsewé K: Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: A systematic review. Eur J Surg Oncol. 36:114–119. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Van Ooijen B, Bontenbal M, Henzen-Logmans SC and Koper PC: Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg. 80:1299–1300. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Hawes D, Neville AM and Cote RJ: Detection of occult metastasis in patients with breast cancer. Semin Surg Oncol. 20:312–318. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Medina-Franco H and Urist MM: Occult breast carcinoma presenting with axillary lymph node metastases. Rev Invest Clin. 54:204–208. 2002.PubMed/NCBI | |
|
Owen HW, Dockerty MB and Gray HK: Occult carcinoma of the breast. Surg Gynecol Obstet. 98:302–308. 1954.PubMed/NCBI | |
|
Chen YC, Chan CH, Lim YB, Yang SF, Yeh LT, Wang YH, Chou MC and Yeh CB: Risk of breast cancer in women with mastitis: A retrospective population-based cohort study. Medicina (Kaunas). 56(372)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ping J, Liu W, Chen Z and Li C: Lymph node metastases in breast cancer: Mechanisms and molecular imaging. Clin Imaging. 103(109985)2023.PubMed/NCBI View Article : Google Scholar | |
|
He M, Liu H and Jiang Y: A case report of male occult breast cancer first manifesting as axillary lymph node metastasis with part of metastatic mucinous carcinoma. Medicine (Baltimore). 94(e1038)2015.PubMed/NCBI View Article : Google Scholar | |
|
Rosen PP and Kimmel M: Occult breast carcinoma presenting with axillary lymph node metastases: A follow-up study of 48 patients. Hum Pathol. 21:518–523. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Hur SM, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE and Yang JH: Occult breast cancers manifesting as axillary lymph node metastasis in men: A two-case report. J Breast Cancer. 15:359–363. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Matsuoka K, Ohsumi S, Takashima S, Saeki T, Aogi K and Mandai K: Occult breast carcinoma presenting with axillary lymph node metastases: Follow-up of eleven patients. Breast Cancer. 10:330–334. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Zheng H, Gu Y, Qin Y, Huang X, Yang J and Yang GZ: Small Lesion Classification in Dynamic Contrast Enhancement MRI for Breast Cancer Early Detection. In: Medical Image Computing and Computer Assisted Intervention-MICCAI 2018. Vol 11071. Frangi AF, Schnabel JA, Davatzikos C, Alberola-López C and Fichtinger G (eds). Springer International Publishing, Cham, pp876-884, 2018. | |
|
Lei YM, Yin M, Yu MH, Yu J, Zeng SE, Lv WZ, Li J, Ye HR, Cui XW and Dietrich CF: Artificial intelligence in medical imaging of the breast. Front Oncol. 11(600557)2021.PubMed/NCBI View Article : Google Scholar | |
|
Uchida K, Yamashita A, Kawase K and Kamiya K: Screening ultrasonography revealed 15% of mammographically occult breast cancers. Breast Cancer. 15:165–168. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Jacob D, Brombart JC, Muller C, Lefèbvre C, Massa F and Depoerck A: Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer. J Gynecol Obstet Biol Reprod (Paris). 26:27–31. 1997.PubMed/NCBI(In French). | |
|
Asbeutah AM, AlMajran AA, Brindhaban A and Asbeutah SA: Comparison of radiation doses between diagnostic full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT): A clinical study. J Med Radiat Sci. 67:185–192. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gøtzsche PC and Jørgensen KJ: Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013(CD001877)2013.PubMed/NCBI View Article : Google Scholar | |
|
Rodríguez-Ruiz A, Krupinski E, Mordang JJ, Schilling K, Heywang-Köbrunner SH, Sechopoulos I and Mann RM: Detection of breast cancer with mammography: Effect of an artificial intelligence support system. Radiology. 290:305–314. 2019.PubMed/NCBI View Article : Google Scholar | |
|
McDonald ES, Hammersley JA, Chou SH, Rahbar H, Scheel JR, Lee CI, Liu CL, Lehman CD and Partridge SC: Performance of DWI as a Rapid unenhanced technique for detecting mammographically occult breast cancer in elevated-risk women with dense breasts. AJR Am J Roentgenol. 207:205–216. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Theunissen CI, Rust EA, Edens MA, Bandel C, Van't Ooster-van den Berg JG, Jager PL, Noorda EM and Francken AB: Radioactive seed localization is the preferred technique in nonpalpable breast cancer compared with wire-guided localization and radioguided occult lesion localization. Nucl Med Commun. 38:396–401. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A and Dershaw DD: MRI of Occult Breast Carcinoma in a High-Risk Population. AJR Am J Roentgenol. 181:619–626. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Buchanan CL, Morris EA, Dorn PL, Borgen PI and Van Zee KJ: Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 12:1045–1053. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wecsler JS, Raghavendra A, Mack WJ, Tripathy D, Yamashita M, Sheth P, Hovanessian-Larsen L, Sener SF, Russell CA, McDonald H and Lang JE: Abstract P4-02-05: Predictors of MRI detection of occult lesions in newly diagnosed breast cancer. Cancer Res. 76 (Suppl 4)(P4-02-05)2016. | |
|
Zheng B, Hollingsworth AB, Tan MY, Stough RG and Liu H: Abstract P4-02-06: Improving efficacy of applying breast MRI to detect mammography-occult breast cancer. Cancer Res. 76 (Suppl 4)(P4-02-06)2016. | |
|
Amornsiripanitch N, Rahbar H, Kitsch AE, Lam DL, Weitzel B and Partridge SC: Visibility of mammographically occult breast cancer on diffusion-weighted MRI versus ultrasound. Clin Imaging. 49:37–43. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Gao Y, Bagadiya NR, Jardon ML, Heller SL, Melsaether AN, Toth HB and Moy L: Outcomes of Preoperative MRI-Guided needle localization of nonpalpable mammographically occult breast lesions. AJR Am J Roentgenol. 207:676–684. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Smith LF, Henry-Tillman R, Mancino AT, Johnson A, Price Jones M, Westbrook KC, Harms S and Klimberg VS: Magnetic resonance imaging-guided core needle biopsy and needle localized excision of occult breast lesions. Am J Surg. 182:414–418. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Ryu JK, Rhee SJ, Song JY, Cho SH and Jahng GH: Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer. J Appl Clin Med Phys. 17:377–390. 2016.PubMed/NCBI View Article : Google Scholar | |
|
McCartan DP, Zabor EC, Morrow M, Van Zee KJ and El-Tamer MB: Oncologic outcomes after treatment for MRI occult breast cancer (pT0N+). Ann Surg Oncol. 24:3141–3147. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ramírez Huaranga MA, Salas Manzanedo V, Huertas MP, Torres Sousa Y and Ramos Rodríguez CC: Lumbar pain as the single manifestation of an occult breast cancer. Usefulness of positron emission tomography. Reumatol Clin. 11:118–120. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Takabatake D, Taira N, Aogi K, Ohsumi S, Takashima S, Inoue T and Nishimura R: Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors. Breast Cancer. 15:181–184. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Brem RF, Ruda RC, Yang JL, Coffey CM and Rapelyea JA: Breast-Specific γ-Imaging for the detection of mammographically occult breast cancer in women at increased risk. J Nucl Med. 57:678–684. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Brem RF, Shahan C, Rapleyea JA, Donnelly CA, Rechtman LR, Kidwell AB, Teal CB, McSwain A and Torrente J: Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol. 17:735–743. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Zand S and Abdolali A: Radioguided Occult Lesion Localisation (ROLL) for Excision of Non-Palpable Breast Lesions, a Personal Experience in a Patient with Multifocal Breast Cancer. Arch Breast Cancer. 3:139–143. 2016. | |
|
Ong JSL, The J, Saunders C, Bourke AG, Lizama C, Newton J, Phillips M and Taylor DB: Patient satisfaction with Radioguided Occult Lesion Localisation using iodine-125 seeds (‘ROLLIS’) versus conventional hookwire localisation. Eur J Surg Oncol. 43:2261–2269. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li H, Liu Z, Yuan L, Fan K, Zhang Y, Cai W and Lan X: Radionuclide-Based imaging of breast cancer: State of the art. Cancers (Basel). 13(5459)2021.PubMed/NCBI View Article : Google Scholar | |
|
Altıparmak Güleç B and Yurt F: Treatment with radiopharmaceuticals and radionuclides in breast cancer: Current options. Eur J Breast Health. 17:214–219. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Tolmachev V and Vorobyeva A: Radionuclides in diagnostics and therapy of malignant tumors: New development. Cancers (Basel). 14(297)2022.PubMed/NCBI View Article : Google Scholar | |
|
Amir E, Bedard PL, Ocaña A and Seruga B: Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst. 104:1542–1547. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Health Commission Of The People's Republic Of China N. National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version). Chin J Cancer Res. 34:151–175. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Yu YH, Qu W, Zhang Y and Li J: Diagnosis and treatment of accessory breast cancer in 11 patients. Oncol Lett. 10:1783–1788. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Pesapane F, Downey K, Rotili A, Cassano E and Koh DM: Imaging diagnosis of metastatic breast cancer. Insights Imaging. 11(79)2020.PubMed/NCBI View Article : Google Scholar | |
|
Feuerman L, Attie JN and Rosenberg B: Carcinoma in axillary lymph nodes as an indicator of breast cancer. Surg Gynecol Obstet. 114:5–8. 1962.PubMed/NCBI | |
|
Larsen RR, Sawyer KC, Sawyer RB and Torres RC: Occult carcinoma of the breast. Am J Surg. 107:553–555. 1964.PubMed/NCBI View Article : Google Scholar | |
|
Osteen RT, Kopf G and Wilson RE: In pursuit of the unknown primary. Am J Surg. 135:494–497. 1978.PubMed/NCBI View Article : Google Scholar | |
|
Chen QX, Wang XX, Lin PY, Zhang J, Li JJ, Song CG and Shao ZM: The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: A population-based study from the SEER 18 database. Oncotarget. 8:4773–4780. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Masinghe SP, Faluyi OO, Kerr GR and Kunkler IH: Breast radiotherapy for occult breast cancer with axillary nodal metastases-does it reduce the local recurrence rate and increase overall survival? Clin Oncol (R Coll Radiol). 23:95–100. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Macedo FI, Eid JJ, Flynn J, Jacobs MJ and Mittal VK: Optimal surgical management for occult breast carcinoma: A meta-analysis. Ann Surg Oncol. 23:1838–1844. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Foroudi F and Tiver KW: Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys. 47:143–147. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Shannon C, Walsh G, Sapunar F, A'Hern R and Smith I: Occult primary breast carcinoma presenting as axillary lymphadenopathy. Breast. 11:414–418. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Buisman FE, van Gelder L, Menke-Pluijmers MB, Bisschops BH, Plaisier PW and Westenend PJ: Non-primary breast malignancies: A single institution's experience of a diagnostic challenge with important therapeutic consequences-a retrospective study. World J Surg Oncol. 14(166)2016.PubMed/NCBI View Article : Google Scholar | |
|
Kemeny MM: Mastectomy: Is it necessary for occult breast cancer? N Y State J Med. 92:516–517. 1992.PubMed/NCBI | |
|
Copeland EM and Mcbride CM: Axillary metastases from unknown primary sites. Ann Surg. 178:21–27. 1973.PubMed/NCBI View Article : Google Scholar | |
|
Kim BH, Kwon J and Kim K: Evaluation of the benefit of radiotherapy in patients with occult breast cancer: A population-based analysis of the SEER database. Cancer Res Treat. 50:551–561. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, et al: Systemic treatment of breast cancer. 1st Central-Eastern European professional consensus statement on breast cancer. Pathol Oncol Res. 28(1610383)2022.PubMed/NCBI View Article : Google Scholar | |
|
Song MW, Ki SY, Lim HS, Lee HJ, Lee JS and Yoon JH: Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: A case report. BMC Womens Health. 21(418)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wu SG, Zhang WW, Sun JY, Li FY, Lin HX, Chen YX and He ZY: Comparable survival between additional radiotherapy and local surgery in occult breast cancer after axillary lymph node dissection: A population-based analysis. J Cancer. 8:3849–3855. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Neal L, Sookhan N and Reynolds C: Occult breast carcinoma presenting as gastrointestinal metastases. Case Rep Med. 2009(564756)2009.PubMed/NCBI View Article : Google Scholar | |
|
Ciulla A, Castronovo G, Tomasello G, Maiorana AM, Russo L, Daniele E and Genova G: Gastric metastases originating from occult breast lobular carcinoma: Diagnostic and therapeutic problems. World J Surg Oncol. 6(78)2008.PubMed/NCBI View Article : Google Scholar | |
|
Khan I, Malik R, Khan A, Assad S, Zahid M, Sohail MS, Yasin F and Qavi AH: Breast cancer metastases to the gastrointestinal tract presenting with Anemia and intra-abdominal bleed. Cureus. 9(e1429)2017.PubMed/NCBI View Article : Google Scholar | |
|
Rodrigues MV, Tercioti-Junior V, Lopes LR, Coelho-Neto Jde S and Andreollo NA: Breast cancer metastasis in the stomach: When the gastrectomy is indicated? Arq Bras Cir Dig. 29:86–89. 2016.PubMed/NCBI View Article : Google Scholar : (In English, Portuguese). | |
|
Yang H, Li L, Zhang M, Zhang S, Xu S and Ma X: Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports. Medicine (Baltimore). 96(e8200)2017.PubMed/NCBI View Article : Google Scholar | |
|
Asaoka M, Gandhi S, Ishikawa T and Takabe K: Neoadjuvant chemotherapy for breast cancer: Past, present, and future. Breast Cancer (Auckl). 14(1178223420980377)2020.PubMed/NCBI View Article : Google Scholar | |
|
Hessler LK, Molitoris JK, Rosenblatt PY, Bellavance EC, Nichols EM, Tkaczuk KHR, Feigenberg SJ, Bentzen SM and Kesmodel SB: Factors influencing management and outcome in patients with occult breast cancer with axillary lymph node involvement: Analysis of the National cancer database. Ann Surg Oncol. 24:2907–2914. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gosset M, Hamy AS, Mallon P, Delomenie M, Mouttet D, Pierga JY, Lae M, Fourquet A, Rouzier R, Reyal F and Feron JG: Prognostic impact of time to ipsilateral breast tumor recurrence after breast conserving surgery. PLoS One. 11(e0159888)2016.PubMed/NCBI View Article : Google Scholar | |
|
Liu YM, Ge JY, Chen YF, Liu T, Chen L, Liu CC, Ma D, Chen YY, Cai YW, Xu YY, et al: Combined single-cell and spatial transcriptomics reveal the metabolic evolvement of breast cancer during early dissemination. Adv Sci (Weinh). 10(2205395)2023.PubMed/NCBI View Article : Google Scholar | |
|
Chagpar AB, Cicek AF and Harigopal M: Can tumor biology predict occult multifocal disease in breast cancer patients? Am Surg. 83:704–708. 2017.PubMed/NCBI | |
|
Merkkola-von Schantz PA, Jahkola TA, Krogerus LA and Kauhanen SMC: Reduction mammaplasty in patients with history of breast cancer: The incidence of occult cancer and high-risk lesions. Breast. 35:157–161. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series. AR 37, 2017. | |
|
Abe H, Naitoh H, Umeda T, Shiomi H, Tani T, Kodama M and Okabe H: Occult breast cancer presenting axillary nodal metastasis: A case report. Jpn J Clin Oncol. 30:185–187. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, et al: Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat. 129:867–875. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Aydoğan F, Taşçı Y and Sagara Y: Phyllodes Tumors of the Breast. In: Breast Disease. Aydiner A, İgci A and Soran A (eds). Springer International Publishing, Cham, pp421-427, 2016. | |
|
Li L, Zhang D, Wen T, Wu Y, Lv D, Zhai J and Ma F: Axillary lymph node dissection plus radiotherapy may be an optimal strategy for patients with occult breast cancer. J National Cancer Center. 2:198–204. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Schwab FD, Burger H, Isenschmid M, Kuhn A, Mueller MD and Günthert AR: Suspicious axillary lymph nodes in patients with unremarkable imaging of the breast. Eur J Obstet Gynecol Reprod Biol. 150:88–91. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Shetty MK and Carpenter WS: Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms. J Ultrasound Med. 23:63–71. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Christiansen P, Carstensen SL, Ejlertsen B, Kroman N, Offersen B, Bodilsen A and Jensen MB: Breast conserving surgery versus mastectomy: Overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol. 57:19–25. 2018.PubMed/NCBI View Article : Google Scholar | |
|
de Boniface J, Szulkin R and Johansson ALV: Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: A Swedish National 6-year follow-up of 48 986 women. JAMA Surg. 156:628–637. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Keelan S, Flanagan M and Hill ADK: Evolving trends in surgical management of breast cancer: An analysis of 30 years of practice changing papers. Front Oncol. 11(622621)2021.PubMed/NCBI View Article : Google Scholar | |
|
Saha A, Mukhopadhyay M, Das C, Sarkar K, Saha AK and Sarkar DK: FNAC Versus core needle biopsy: A comparative study in evaluation of palpable breast lump. J Clin Diagn Res. 10:EC05–EC08. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lieske B, Ravichandran D and Wright D: Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 95:62–66. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Willems SM, Van Deurzen CHM and Van Diest PJ: Diagnosis of breast lesions: Fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol. 65:287–292. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Calhoun BC and Collins LC: Predictive markers in breast cancer: An update on ER and HER2 testing and reporting. Semin Diagn Pathol. 32:362–369. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Onitilo AA, Engel JM, Greenlee RT and Mukesh BN: Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival. Clin Med Res. 7:4–13. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Wang R, Yang HX, Chen J, Huang JJ and Lv Q: Best treatment options for occult breast cancer: A meta-analysis. Front Oncol. 13(1051232)2023.PubMed/NCBI View Article : Google Scholar | |
|
Tsai C, Zhao B, Chan T and Blair SL: Treatment for occult breast cancer: A propensity score analysis of the National Cancer Database. Am J Surg. 220:153–160. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mariscotti G, Houssami N, Durando M, Bergamasco L, Campanino PP, Ruggieri C, Regini E, Luparia A, Bussone R, Sapino A, et al: Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer. Anticancer Res. 34:1219–1225. 2014.PubMed/NCBI | |
|
Kim WH, Chang JM, Moon HG, Yi A, Koo HR, Gweon HM and Moon WK: Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers. Eur Radiol. 26:1556–1564. 2016.PubMed/NCBI View Article : Google Scholar | |
|
An YY, Kim SH and Kang BJ: Characteristic features and usefulness of MRI in breast cancer in patients under 40 years old: Correlations with conventional imaging and prognostic factors. Breast Cancer. 21:302–315. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I and Parizel P: Magnetic resonance imaging in breast cancer. Eur J Surg Oncol. 32:901–910. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zeeshan M, Salam B, Khalid QSB, Alam S and Sayani R: Diagnostic accuracy of digital mammography in the detection of breast cancer. Cureus. 10(e2448)2018.PubMed/NCBI View Article : Google Scholar | |
|
Li H, Mendel KR, Lan L, Sheth D and Giger ML: Digital mammography in breast cancer: Additive value of radiomics of breast parenchyma. Radiology. 291:15–20. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Seeram E: Full-Field Digital Mammography. In: Digital Radiography. Springer Singapore, Singapore, pp111-123, 2019. | |
|
Jadvar H and Colletti PM: Competitive advantage of PET/MRI. Eur J Radiol. 83:84–94. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Koolen BB, Vidal-Sicart S, Benlloch Baviera JM and Valdés Olmos RA: Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): A feasibility study based on correlation with PET/CT. Nucl Med Commun. 35:446–452. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Singh BK, Verma K and Thoke AS: Fuzzy cluster based neural network classifier for classifying breast tumors in ultrasound images. Exp Sys Appl. 66:114–123. 2016. | |
|
Gómez-Flores W and Ruiz-Ortega BA: New fully automated method for segmentation of breast lesions on ultrasound based on texture analysis. Ultrasound Med Biol. 42:1637–1650. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kozegar E, Soryani M, Behnam H, Salamati M and Tan T: Breast cancer detection in automated 3D breast ultrasound using iso-contours and cascaded RUSBoosts. Ultrasonics. 79:68–80. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mohammed MA, Al-Khateeb B, Rashid AN, Ibrahim DA, Abd Ghani MK and Mostafa SA: Neural network and multi-fractal dimension features for breast cancer classification from ultrasound images. Comp Elect Eng. 70:871–882. 2018. | |
|
Moon WK, Chen IL, Yi A, Bae MS, Shin SU and Chang RF: Computer-aided prediction model for axillary lymph node metastasis in breast cancer using tumor morphological and textural features on ultrasound. Comput Methods Programs Biomed. 162:129–137. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Kim SA, Chang JM, Cho N, Yi A and Moon WK: Characterization of breast lesions: Comparison of digital breast tomosynthesis and ultrasonography. Korean J Radiol. 16:229–238. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cai SQ, Yan JX, Chen QS, Huang ML and Cai DL: Significance and application of digital breast tomosynthesis for the BI-RADS classification of breast cancer. Asian Pac J Cancer Prev. 16:4109–4114. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Nakashima K, Uematsu T, Itoh T, Takahashi K, Nishimura S, Hayashi T and Sugino T: Comparison of visibility of circumscribed masses on Digital Breast Tomosynthesis (DBT) and 2D mammography: Are circumscribed masses better visualized and assured of being benign on DBT? Eur Radiol. 27:570–577. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mercier J, Kwiatkowski F, Abrial C, Boussion V, Dieu-de Fraissinette V, Marraoui W, Petitcolin-Bidet V and Lemery S: The role of tomosynthesis in breast cancer staging in 75 patients. Diagn Interv Imaging. 96:27–35. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Roganovic D, Djilas D, Vujnovic S, Pavic D and Stojanov D: Breast MRI, digital mammography and breast tomosynthesis: Comparison of three methods for early detection of breast cancer. Bosn J Basic Med Sci. 15:64–68. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Das BK, Biswal BM and Bhavaraju M: Role of scintimammography in the diagnosis of breast cancer. Malays J Med Sci. 13:52–57. 2006.PubMed/NCBI | |
|
Simanek M and Koranda P: SPECT/CT imaging in breast cancer-current status and challenges. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 160:474–483. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Berrington de González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F and Land C: Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 169:2071–2077. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T and Mathur V: Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology. 247:651–657. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Yoon HJ, Kim Y, Chang KT and Kim BS: Prognostic value of semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer. Ann Nucl Med. 29:553–560. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Tan H, Zhang H, Yang W, Fu Y, Gu Y, Du M, Cheng D and Shi H: Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics. Nucl Med Commun. 37:792–799. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Yu X, Hu G, Zhang Z, Qiu F, Shao X, Wang X, Zhan H, Chen Y, Deng Y and Huang J: Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women. BMC Cancer. 16(450)2016.PubMed/NCBI View Article : Google Scholar | |
|
Cho MJ, Yang JH, Yu YB, Park KS, Chung HW, So Y, Choi N and Kim MY: Validity of breast-specific gamma imaging for Breast Imaging Reporting and Data System 4 lesions on mammography and/or ultrasound. Ann Surg Treat Res. 90:194–200. 2016.PubMed/NCBI View Article : Google Scholar |
